Journal of Drug Vigilance and Alternative Therapies <p><strong>WELCOME TO JDVAT</strong></p> <p><strong>Journal of Drug Vigilance and Alternative Therapies (JDVAT)</strong> is a quarterly international scientific journal published by <strong>Multidisciplinary Scientific Research Institute (MSRI)</strong> addressing the disciplines of <strong>pharmacology,</strong> <strong>pharmacovigilance, toxicology, complementary</strong> and <strong>alternative medicines</strong>. The main aim of JDVAT is to detect and assess adverse reactions arising through the use of drug molecules and to mitigate them with <strong>traditional, conventional, alternative, complementary </strong>and<strong> combination</strong> therapies of different systems of medicines including practices of acupuncture, anthroposophy, biofeedback, eclecticism, kinesiology, moxibustion, organotherapy, rejuvenation etc.</p> <p>The JDVAT is also associated with the study and scientific investigation of the biological processes of materials derived from plants, animals, and minerals used in various healthcare programs such as <strong>Allopathy, Ayurveda, Siddha, Yoga, Homeopathy, Unani, Naturopathy, Nutraceuticals, Phytomedicines </strong>etc. in order to provide alternative treatment and avoid therapies with high adverse effects.</p> <p>Through publishing original research articles, review articles, case reports, perspectives, and short communications, JDVAT promotes the effective use of pharmacotherapy by providing advice on safe and appropriate medication prescribing, global communication of adverse drug reactions, and various approaches to reduce side effects.</p> en-US (Chief Editor: Dr. Sumia Fatima) (Ubitech Solutions Pvt Ltd) Fri, 30 Dec 2022 00:00:00 +0000 OJS 60 Evaluation of Antiepileptic Activity of Prunus amygdalus Dry Fruit Suspension in Albino Mice <p>Epilepsy, a prevalent neurological disorder, poses a substantial global health burden affecting individuals of all ages. Despite the availability of antiepileptic drugs (AEDs), a considerable proportion of patients face challenges in achieving adequate seizure control, prompting exploration into alternative therapies. This research focuses on evaluating the antiepileptic activity of Prunus amygdalus (PA) dry fruit suspension in albino mice following the induction of convulsions through maximum electric shock (MES) &amp; isoniazidinduced tonic-clonic seizures, and strychnine-induced convulsive seizures. The study reveals that 100, 200, and 400 mg/kg doses of Prunus amygdalus suspension administered orally significantly reduces the frequency and amplitude of induced movements. The duration of convulsions was reduced significantly also for both clonic and tonic seizures as well. The antiepileptic activity of Prunus amygdalus is attributed to its impact on Na+ voltage-dependent channels or acting as an NMDA antagonist. The presence of alkaloids and flavonoids in PA suspension aligns with established evidence supporting their antiepileptic effects. This study offers insightful information into the development of plant-based alternatives for epilepsy management, paving the way for further investigations into the therapeutic potential of Prunus amygdalus in neurological disorders.</p> Ahmed Bin Osman, B. V. Kishore Copyright (c) 2024 Sat, 31 Dec 2022 00:00:00 +0000 Antioxidant and Antihyperlipidemic Activities of Methanolic Extract of Rubia cordifolia Roots <p>Hyperlipidemia, characterized by elevated cholesterol and triglyceride levels, poses a significant global health challenge with substantial implications for cardiovascular well-being. This study investigated the anti-hyperlipidemic potential of the methanolic root extract of Rubia cordifolia (MERC) using rat models induced with hyperlipidemia through a high-fat diet. Hyperlipidemia was induced by administering a highfat diet to rats for a duration of 4 weeks. MERC exhibited notable antioxidant activity in DPPH and reducing power assays. Treatment with MERC at doses of 200 and 400 mg/kg orally significantly mitigated hyperlipidemia, evidenced by reduced levels of serum Total Cholesterol (TC), Triglycerides (TG), LowDensity Lipoprotein Cholesterol (LDLC), and an increase in serum High-Density Lipoprotein Cholesterol (HDLC) compared to the vehicle control and the standard drug Atorvastatin. These findings underscore the substantial anti-hyperlipidemic activity of the methanolic root extract of Rubia cordifolia.</p> Mohammed Hamed Ali, Uzma Taseen Copyright (c) 2024 Fri, 30 Dec 2022 00:00:00 +0000